Hvis præparatet administreres i en eksisterende intravenøs infusionsslange, skal infusionsvæsken begrænses til enten isotonisk saltvand eller 50 mg/ ml (5%) glucoseopløsning.
Where the product is administered into an existing intravenous infusion line, the infusate should be restricted to either isotonic saline or 50 mg/ ml (5%) glucose solution.